Literature DB >> 16695058

STUDIES IN CANCER. VII. ENZYME DEFICIENCY IN HUMAN AND EXPERIMENTAL CANCER.

R C Roskelley1, N Mayer, B N Horwitt, W T Salter.   

Abstract

Entities:  

Year:  1943        PMID: 16695058      PMCID: PMC435291          DOI: 10.1172/JCI101447

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  1 in total

1.  COENZYME I AND RIBOFLAVIN CONTENT OF LIVERS OF RATS FED BUTTER YELLOW.

Authors:  C J Kensler; K Suguira; C P Rhoads
Journal:  Science       Date:  1940-06-28       Impact factor: 47.728

  1 in total
  8 in total

1.  [The biological oxidation and glycolysis in tumors].

Authors:  C G SCHMIDT
Journal:  Klin Wochenschr       Date:  1955-05-01

2.  The incorporation of C 14 glycine into protein by human liver slices.

Authors:  C M GROSSMAN; J D HAUSCHILDT
Journal:  J Clin Invest       Date:  1952-02       Impact factor: 14.808

3.  Observations on the reduction of triphenyl tetrazolium chloride by normal and malignant human tissue.

Authors:  M M BLACK; S R OPLER; F D SPEER
Journal:  Am J Pathol       Date:  1950-11       Impact factor: 4.307

4.  Cancer as a metabolic disease.

Authors:  Thomas N Seyfried; Laura M Shelton
Journal:  Nutr Metab (Lond)       Date:  2010-01-27       Impact factor: 4.169

Review 5.  Curious Cases of the Enzymes.

Authors:  Nuriye Nuray Ulusu
Journal:  J Med Biochem       Date:  2015-07-14       Impact factor: 3.402

6.  QUANTITATIVE HISTOCHEMISTRY: LEVELS OF CERTAIN OXIDATIVE ENZYMES IN SECONDARY NEOPLASIA FOUND IN A RAT AFTER FEEDING 4-DIMETHYLAMINOAZOBENZENE.

Authors:  G R JONES
Journal:  Br J Cancer       Date:  1965-06       Impact factor: 7.640

7.  Cancer as a mitochondrial metabolic disease.

Authors:  Thomas N Seyfried
Journal:  Front Cell Dev Biol       Date:  2015-07-07

Review 8.  Cancer as a metabolic disease: implications for novel therapeutics.

Authors:  Thomas N Seyfried; Roberto E Flores; Angela M Poff; Dominic P D'Agostino
Journal:  Carcinogenesis       Date:  2013-12-16       Impact factor: 4.944

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.